Genus plc Logo

Genus plc

LON-GNS
London Stock Exchange NYSE
Healthcare Biotechnology
Global Rank
#6599
Country Rank
#203
Market Cap
1.76 B
Price
2,684.9
Change (%)
0.40%
Volume
154,053

Genus plc's latest marketcap:

1.76 B

As of 06/10/2025, Genus plc's market capitalization has reached $1.76 B. According to our data, Genus plc is the 6599th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.76 B
Revenue (ttm) 909.78 M
Net Income (ttm) -5,418,560
Shares Out 65.69 M
EPS (ttm) -0.08
Forward PE 26.28
Ex-Dividend Date 03/06/2025
Earnings Date 09/04/2025
Market Cap Chart
Data Updated: 06/10/2025

Genus plc's yearly market capitalization.

Genus plc has seen its market value drop from £2.72 B to £1.3 B since 2020, representing a total decrease of 52.21% and an annual compound decline rate (CAGR) of 15.32%.
Date Market Cap Change (%)
06/10/2025 £1.3 B 28.39%
12/31/2024 £1.02 B -28.43%
12/29/2023 £1.42 B -27.1%
12/30/2022 £1.95 B -39.35%
12/31/2021 £3.22 B 18.11%
12/31/2020 £2.72 B

Company Profile

About Genus plc

Genus plc is a leading animal genetics company operating across multiple regions, including North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia.

Business Segments

  • Genus PIC: Specializes in breeding pigs and supplying semen for pork production under the PIC brand.
  • Genus ABS: Provides bull semen and embryos for dairy and beef cattle breeding under the ABS, Genus, and Bovec brands.
  • Genus Research and Development: Focuses on advancing genetic innovations and technical services for farmers.

Key Offerings

Genus plc delivers high-quality breeding solutions, including:

  • Pig genetics for optimized pork production.
  • Cattle genetics for enhanced milk and beef yields.
  • Technical support and expertise for livestock farmers.

Founded in 1994 and headquartered in Basingstoke, UK, Genus plc continues to drive advancements in animal genetics worldwide.

Frequently Asked Questions

  • What is Genus plc's (LON-GNS) current market cap?
    As of 06/10/2025, Genus plc (including the parent company, if applicable) has an estimated market capitalization of $1.76 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Genus plc global market capitalization ranking is approximately 6599 as of 06/10/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.